Skip to content
Open access

Bacteroides fragilis Enterotoxin Activates NLRP3 Inflammasomes through NF-κB Signaling and Mitophagy Suppression in Intestinal Epithelial Cells.

Oct 2026 · Gut and Liver · 0 citations
Medicine

Abstract

Background/Aims Enterotoxigenic Bacteroides fragilis (ETBF) induces acute and chronic inflammatory pathology through its toxic factor B. fragilis enterotoxin (BFT). Although inflammasomes are critical for maintaining intestinal homeostasis and modulating inflammation, their roles remain poorly characterized during ETBF infection. This study investigated the pathways involved in inflammasome formation in BFT-exposed intestinal epithelial cells (IECs). Methods Human colon epithelial cells HCT-116 and CCD 841 CoN were used as IEC models. To investigate inflammasome formation and activation, BFT-treated cells were analyzed by immunoblotting, disuccinimidyl suberate cross-linking, immunofluorescence microscopy, colocalization assays, and enzyme-linked immunosorbent assay. Results BFT stimulation significantly upregulated the expression of NLR family pyrin domain containing 3 (NLRP3), pro-interleukin (IL)-1β, pro-IL-18, and cleaved caspase-1 in both cell lines. Inflammasome complexes were confirmed by apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization and colocalization of ASC with NLRP3, accompanied by increased IL-1β and IL-18 secretion. Two pathways were involved in inflammasome activation: first, nuclear factor kappa B (NF-κB) signaling regulated NLRP3, pro-IL-1β, and pro-IL-18 expression, promoting caspase-1 activation; second, p53/BAG5 axis activation suppressed Parkin-mediated mitophagy and drove reactive oxygen species accumulation, engaging the inflammasome complex. Conclusions These findings demonstrate that the formation of inflammasomes may occur via two pathways, namely, NF-κB-mediated signaling and p53/BAG5-associated suppression of mitophagy.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.